OpenLegislation

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)

EU Regulation No 2377/1990 · Adopted 26 June 1990 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Council Regulation (EEC) No 2377/90

of 26 June 1990

laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Repealed by Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (Text with EEA relevance).

Contents

  1. 1Article 1 Repealed
  2. 2Article 2 Repealed
  3. 3Article 3 Repealed
  4. 4Article 4 Repealed
  5. 5Article 5 Repealed
  6. 6Article 6 Repealed
  7. 7Article 7 Repealed
  8. 8Article 8 Repealed
  9. 9Article 9 Repealed
  10. 10Article 10 Repealed
  11. 11Article 11 Repealed
  12. 12Article 12 Repealed
  13. 13Article 13 Repealed
  14. 14Article 14 Repealed
  15. 15Article 15 Repealed
  16. 16Article 16 Repealed
  17. Signature
  18. Annex I: LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED Repealed
  19. Anti-infectious agents Repealed
  20. Chemotheurapeutics Repealed
  21. 1.1.1Sulfonamides Repealed
  22. 1.1.2Diamino pyrimidine derivatives Repealed
  23. Antibiotics Repealed
  24. 1.2.1Penicillins Repealed
  25. 1.2.2Cephalosporins Repealed
  26. 1.2.3Quinolones Repealed
  27. 1.2.4Macrolides Repealed
  28. 1.2.5Florfenicol and related compounds Repealed
  29. 1.2.6Tetracyclines Repealed
  30. 1.2.7Naphtalene-ringed ansamycin Repealed
  31. 1.2.8Pleuromutilines Repealed
  32. 1.2.9Lincosamides Repealed
  33. 1.2.10Aminoglycosides Repealed
  34. 1.2.11Other antibiotics Repealed
  35. 1.2.12Polypeptides Repealed
  36. 1.2.13Beta-lactamase inhibitors Repealed
  37. 1.2.14Polymyxins Repealed
  38. 1.2.15Orthosomycins Repealed
  39. 1.2.16Ionophores Repealed
  40. Antiparasitic agents Repealed
  41. Agents acting against endoparasites Repealed
  42. 2.1.1Salicylanilides Repealed
  43. 2.1.2Tatra-hydro-imidazoles (imidazolthiazoles) Repealed
  44. 2.1.3Benzimidazoles and pro-benzimidazoles Repealed
  45. 2.1.4Phenol derivatives including salicylanides Repealed
  46. 2.1.5Benzenesulphonamides Repealed
  47. 2.1.6Piperazine derivatives Repealed
  48. 2.1.7Tetrahydropyrimides Repealed
  49. 2.1.8Others Repealed
  50. Agents acting against ectoparasites Repealed
  51. 2.2.1Organophosphates Repealed
  52. 2.2.2Formamidines Repealed
  53. 2.2.3Pyrethroids Repealed
  54. 2.2.4Acyl urea derivatives Repealed
  55. 2.2.5Pyrimidines derivatives Repealed
  56. 2.2.6Triazine derivatives Repealed
  57. Agents acting against endo- and ectoparasites Repealed
  58. 2.3.1Avermectins Repealed
  59. Agents acting against protozoa Repealed
  60. 2.4.1Triazinetrione derivative Repealed
  61. 2.4.2Quinazolone derivatives Repealed
  62. 2.4.3Carbanilides Repealed
  63. 2.4.4Ionophores Repealed
  64. Agents acting on the nervous system Repealed
  65. Agents acting on the central nervous system Repealed
  66. 3.1.1Butyrophenone tranquillisers Repealed
  67. Agents acting on the autonomic nervous system Repealed
  68. 3.2.1Anti-adrenergics Repealed
  69. 3.2.2β2 sympathomimetic agents Repealed
  70. Anti-inflammatory agents Repealed
  71. Nonsteroidal anti-inflammatory agents Repealed
  72. 4.1.1Arylpropionic acid derivative Repealed
  73. 4.1.2Fenamate group derivatives Repealed
  74. 4.1.3Enolic acid derivates Repealed
  75. 4.1.4Oxican derivatives Repealed
  76. 4.1.5Pyrazolone derivatives Repealed
  77. 4.1.6Phenyl acetic acid derivatives Repealed
  78. 4.1.7Sulphonated fenyl lactones Repealed
  79. Corticoides Repealed
  80. 5.1Glucocorticoides Repealed
  81. Agents acting on the reproductive system Repealed
  82. 6.1Progestogens Repealed
  83. Annex II: LIST OF SUBSTANCES NOT SUBJECT TO MAXIMUM RESIDUE LIMITS Repealed
  84. 1Inorganic chemicals Repealed
  85. 2Organic compounds Repealed
  86. 3Substances generally recognised as safe Repealed
  87. 4Substances used in homeopathic veterinary medicinal products Repealed
  88. 5Substances used as food additives in foodstuffs for human consumption Repealed
  89. 6Substances of vegetable origin Repealed
  90. 7Anti-infectious agents Repealed
  91. 8Anti-inflammatory agents Repealed
  92. Annex III: LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED Repealed
  93. Anti-infectious agents Repealed
  94. Chemotheurapeutics Repealed
  95. 1.1.2Benzenesulphonamides Repealed
  96. Antibiotics Repealed
  97. 1.2.1Beta-lactamase inhibitors Repealed
  98. 1.2.2Macrolides Repealed
  99. 1.2.4Cephalosporins Repealed
  100. 1.2.5Aminoglycosides Repealed
  101. 1.2.6Quinolones Repealed
  102. 1.2.9Polymyxins Repealed
  103. 1.2.10Penicillins Repealed
  104. 1.2.11Florfenicol and related compounds Repealed
  105. 1.2.12Polypeptides Repealed
  106. 1.2.13Lincosamides Repealed
  107. 1.2.14Pleuromutilines Repealed
  108. Antiparasitic agents Repealed
  109. Agents acting against endoparasites Repealed
  110. 2.1.1Phenol derivatives including salicylanides Repealed
  111. 2.1.2Benzimidazoles and pro-benzimidazoles Repealed
  112. 2.1.3Tetrahydropyrimides Repealed
  113. 2.1.5Piperazine derivatives Repealed
  114. 2.1.6Salicylanilides Repealed
  115. 2.1.8Others Repealed
  116. Agents acting against ectoparasites Repealed
  117. 2.2.1Formamidines Repealed
  118. 2.2.2Iminophenyl thiazolidine derivative Repealed
  119. 2.2.3Pyretrin and pyrethroids Repealed
  120. 2.2.4Organophosphates Repealed
  121. 2.2.5Acyl urea derivates Repealed
  122. 2.2.6Pyrimidines derivatives Repealed
  123. 2.2.7Triazine derivatives Repealed
  124. Agents acting against endo- and ectoparasites Repealed
  125. 2.3.1Avermectins Repealed
  126. Agents acting against protozoa Repealed
  127. 2.4.1Carbanilides Repealed
  128. 2.4.2Quinazolone derivatives Repealed
  129. 2.4.3Triazinetrione derivatives Repealed
  130. 2.4.4Other anti-protozoal agents Repealed
  131. 2.4.5Ionophores Repealed
  132. Agents acting on the nervous system Repealed
  133. Agents acting on the autonomic nervous system Repealed
  134. 3.2.1β 2 sympathomimetic agents Repealed
  135. 3.2.2Anti-adrenergics Repealed
  136. Anti-inflammatory agents Repealed
  137. Nonsteroidal anti-inflammatory agents Repealed
  138. 5.1.1Arylpropionic acid derivative Repealed
  139. 5.1.2Enolic acid derivates Repealed
  140. 5.1.3Pyrazolone derivatives Repealed
  141. 5.1.4Sulfonated phenyl lactones Repealed
  142. Agents acting on the reproductive system Repealed
  143. 6.1Progestogens Repealed
  144. Corticoids Repealed
  145. 7.1Glucocorticoids Repealed
  146. Annex IVLIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH NO MAXIMUM LEVELS CAN BE FIXED Repealed
  147. Annex V: Information and particulars to be included in an application for the establishment of a maximum residue limit for a pharmacologically active substance used in veterinary medicinal products Repealed
  148. Administrative particulars Repealed
  149. 1Division 1 Repealed
  150. 2Division 2 Repealed
  151. 3Division 3 Repealed
  152. 4Division 4 Repealed
  153. 5Division 5 Repealed
  154. 6Division 6 Repealed
  155. Safety documentation Repealed
  156. A.0Division A.0 Repealed
  157. Precise identification of the substance concerned by the application Repealed
  158. 1.1Division 1.1 Repealed
  159. 1.2Division 1.2 Repealed
  160. 1.3Division 1.3 Repealed
  161. 1.4Classification: Repealed
  162. 1.5Division 1.5 Repealed
  163. 1.6Division 1.6 Repealed
  164. 1.7Division 1.7 Repealed
  165. 1.8Division 1.8 Repealed
  166. 1.9Division 1.9 Repealed
  167. 1.10Division 1.10 Repealed
  168. 1.11Description of physical properties: Repealed
  169. Relevant pharmacological studies Repealed
  170. 2.1Division 2.1 Repealed
  171. 2.2Division 2.2 Repealed
  172. Toxicological studies Repealed
  173. 3.1Division 3.1 Repealed
  174. 3.2Division 3.2 Repealed
  175. 3.3Division 3.3 Repealed
  176. Reproductive toxicity, including teratogenicity. Repealed
  177. 3.4.1Division 3.4.1 Repealed
  178. 3.4.2Division 3.4.2 Repealed
  179. 3.5Division 3.5 Repealed
  180. 3.6Division 3.6 Repealed
  181. Studies of other effects Repealed
  182. 4.1Division 4.1 Repealed
  183. Microbiological properties of residues. Repealed
  184. 4.2.1Division 4.2.1 Repealed
  185. 4.2.2Division 4.2.2 Repealed
  186. 4.3Division 4.3 Repealed
  187. Residue documentation Repealed
  188. B.0Division B.0 Repealed
  189. B.1Precise identification of the substance concerned by the application Repealed
  190. Residue studies Repealed
  191. 2.1Pharmacokinetics Repealed
  192. 2.2Division 2.2 Repealed
  193. 2.3Division 2.3 Repealed
  194. Routine analytical method for the detection of residues Repealed
  195. 3.1Division 3.1 Repealed
  196. Validation of the method. Repealed
  197. 3.2.1Division 3.2.1 Repealed
  198. 3.2.2Division 3.2.2 Repealed
  199. 3.2.3Division 3.2.3 Repealed
  200. 3.2.4Division 3.2.4 Repealed
  201. 3.2.5Division 3.2.5 Repealed
  202. 3.2.6Division 3.2.6 Repealed
  203. 3.2.7Division 3.2.7 Repealed